OSI Systems, Inc. Form 10-Q Summary
Reporting period: Fiscal third quarter and nine months ended March 31, 2022. The provided metadata identifies “2021 Q3,” but the filing itself is for fiscal 2022 Q3. Financial statements are unaudited and presented under U.S. GAAP.
Business Context
OSI Systems designs and manufactures specialized electronic systems and components for security and inspection, healthcare, defense, aerospace and related markets. Operations comprise Security, Healthcare, and Optoelectronics and Manufacturing divisions.
Key Financial Metrics
| Metric | Q3 FY2021 | Q3 FY2022 | YTD FY2021 | YTD FY2022 |
|---|---|---|---|---|
| Net revenues | $283.8 million | $290.5 million | $814.7 million | $846.4 million |
| Gross profit | $104.0 million | $102.9 million | $301.9 million | $302.0 million |
| Gross margin | 36.7% | 35.4% | 37.1% | 35.7% |
| Operating income | $32.5 million | $28.4 million | $81.5 million | $82.2 million |
| Net income | $18.8 million | $42.7 million | $48.2 million | $81.6 million |
| Diluted EPS | $1.03 | $2.41 | $2.63 | $4.52 |
| Cash flow from operations | Not separately provided | Not separately provided | $131.1 million | $41.8 million |
Q3 FY2022 net income included $27.4 million of other income, principally a gain on the sale-leaseback of the Hawthorne, California property. Excluding this unusual gain, reported profitability was materially lower than the headline net income suggests. The effective tax rate declined to 20.1% in Q3 from 33.7% in the prior-year quarter and to 20.8% from 30.1% for the nine-month period.
- Revenue mix: Q3 Security revenue increased 4.8% to $158.6 million; Healthcare declined 3.3% to $52.2 million; Optoelectronics and Manufacturing increased 1.7% to $79.7 million.
- Liquidity: Cash and equivalents were $83.3 million at March 31, 2022, up from $80.6 million at June 30, 2021. Approximately 79% of cash was held by foreign subsidiaries.
- Working capital: Inventories increased to $344.6 million from $294.2 million at June 30, 2021, while accounts receivable declined to $282.9 million from $290.7 million.
- Debt: Total debt was $298.0 million, including $247.3 million principal amount of convertible notes due September 1, 2022, a $50.0 million term loan, and $73.0 million drawn on the revolving facility. The current portion of debt was $249.3 million.
- Credit availability: The amended senior secured facility provides $750 million of aggregate capacity. At March 31, 2022, $441.8 million remained available under the revolver and $100 million under the delayed-draw term loan, before considering other facility limitations.
- Share repurchases: The company repurchased 1.12 million shares for $96.8 million during the nine months and had 1.43 million shares remaining under its authorization at March 31, 2022.
Material Changes Versus the Prior Comparable Period
- Revenue increased 2.4% in Q3 and 3.9% for the nine months, led by Security and Optoelectronics and Manufacturing.
- Gross margin compressed because of unfavorable mix, higher component, raw-material, freight and travel costs, and lower Healthcare revenue.
- Q3 operating income declined 12.4% despite higher revenue, primarily due to lower gross profit, higher research and development expense, and $1.5 million of restructuring and other charges versus a $0.3 million prior-year benefit.
- Nine-month operating income was broadly stable; operating expenses declined slightly because prior-year costs included substantial Mexico contract exit charges, partially offset by higher research and development spending.
- Operating cash flow fell by $89.2 million year over year to $41.8 million, driven principally by inventory growth, lower accounts payable and working-capital changes.
- Interest and other expense declined to $2.3 million in Q3 and $6.5 million for the nine months, partly because of the early adoption of ASU 2020-06, which reduced non-cash convertible-debt interest expense.
- The company completed two small Security acquisitions in February 2022 for approximately $15.1 million upfront, with potential contingent consideration of up to approximately $25 million for one acquisition.
Outlook, Risks and Unusual Items
Management stated that available cash, operating cash flow and credit facilities are expected to fund operational needs for the next 12 months and the foreseeable future. No specific revenue or earnings guidance is provided in the filing.
- COVID-19 continues to affect customer order timing, aviation and cargo demand, manufacturing operations, supply chains and revenue recognition.
- Electronic-component shortages, freight constraints, inflation in materials and logistics costs, and the Russia-Ukraine conflict may pressure margins and disrupt supply and customer support. The company also has certain Healthcare research and development activities in Ukraine.
- The Hawthorne sale-leaseback generated $32.0 million of proceeds and a $27.4 million gain. The company entered into a six-year lease with two five-year renewal options.
- The company paid a $12.5 million settlement in the Arkansas Teacher Retirement System securities litigation; $4.5 million was reimbursed by insurance during the quarter and the remaining $8.0 million was reimbursed in April 2022.
- Remaining performance obligations were approximately $372.8 million at March 31, 2022, with approximately 41% expected to be recognized over the next 12 months.
- Potential future acquisition-related contingent payments were capped at $52.4 million, and contingent consideration liabilities totaled $28.3 million.
- The convertible notes mature September 1, 2022. The company repurchased and cancelled approximately $40.2 million principal amount during Q3, leaving approximately $247.3 million principal outstanding at March 31, 2022.
- Environmental and other legal contingencies were not accrued because management does not consider unfavorable outcomes probable and reasonably estimable; adverse resolutions could nevertheless be material.
Investor Verification Points
- Reconcile reported Q3 net income and EPS to the $27.4 million property-sale gain and assess normalized profitability.
- Monitor the September 2022 convertible-note maturity, refinancing or repayment plans, and related liquidity requirements.
- Evaluate whether inventory growth and reduced operating cash flow reflect temporary supply-chain investment or deteriorating working-capital efficiency.
- Track gross-margin recovery amid component, freight, labor and mix pressures.
- Verify the timing and conversion of the $372.8 million remaining performance obligations, particularly in the Security division.
- Assess continuing exposure to COVID-19, Russia-Ukraine disruptions, supply shortages, government procurement timing, legal proceedings and environmental contingencies.